Canan Nebigil
Affiliations: | Duke University, Durham, NC |
Google:
"Canan Nebigil"Mean distance: (not calculated yet)
Parents
Sign in to add mentorRobert J. Lefkowitz | post-doc | Duke | |
Donald P Bottaro | post-doc | 1996-1997 | University of Strasbourg, France (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vincenzi M, Kremic A, Jouve A, et al. (2023) . Pharmacological Reviews |
Demir F, Urayama K, Audebrand A, et al. (2021) Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies. Hypertension (Dallas, Tex. : 1979). 77: 1559-1570 |
Gasser A, Chen YW, Audebrand A, et al. (2019) Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection. Jacc. Cardiooncology. 1: 84-102 |
Nebigil CG, Désaubry L. (2019) The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT). Trends in Cardiovascular Medicine. 29: 200-204 |
Gasser A, Chen Y, Audebrand A, et al. (2019) Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection Jacc: Cardiooncology. 1: 84-102 |
Qureshi R, Kindo M, Boulberdaa M, et al. (2018) A prokineticin-driven epigenetic switch regulates human epicardial cell stemness and fate. Stem Cells (Dayton, Ohio) |
Qureshi R, Kindo M, Arora H, et al. (2017) Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells. Scientific Reports. 7: 12804 |
Arora H, Boulberdaa M, Qureshi R, et al. (2016) Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development. Scientific Reports. 6: 25541 |
Gasser A, Brogi S, Urayama K, et al. (2015) Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1. Plos One. 10: e0121027 |
Désaubry L, Zhao Q, Basmadjian C, et al. (2015) P5.02Development of Novel Anticancer Agents that Target Prohibitins and the Translation Initiation Factor eIF4A Annals of Oncology. 26 |